78 related articles for article (PubMed ID: 23975835)
1. Female-specific rectal carcinogenesis in cyclin D1b transgenic mice.
Kim CJ; Tambe Y; Mukaisho K; Sugihara H; Isono T; Sonoda H; Shimizu T; Kondoh G; Inoue H
Carcinogenesis; 2014 Jan; 35(1):227-36. PubMed ID: 23975835
[TBL] [Abstract][Full Text] [Related]
2. Akt-dependent activation of Erk by cyclin D1b contributes to cell invasiveness and tumorigenicity.
Kim CJ; Tambe Y; Mukaisho KI; Sugihara H; Kawauchi A; Inoue H
Oncol Lett; 2016 Dec; 12(6):4850-4856. PubMed ID: 28105192
[TBL] [Abstract][Full Text] [Related]
3. Cyclin D1b variant promotes cell invasiveness independent of binding to CDK4 in human bladder cancer cells.
Kim CJ; Nishi K; Isono T; Okuyama Y; Tambe Y; Okada Y; Inoue H
Mol Carcinog; 2009 Oct; 48(10):953-64. PubMed ID: 19415719
[TBL] [Abstract][Full Text] [Related]
4. Anti-oncogenic activities of cyclin D1b siRNA on human bladder cancer cells via induction of apoptosis and suppression of cancer cell stemness and invasiveness.
Kim CJ; Terado T; Tambe Y; Mukaisho KI; Sugihara H; Kawauchi A; Inoue H
Int J Oncol; 2018 Jan; 52(1):231-240. PubMed ID: 29115414
[TBL] [Abstract][Full Text] [Related]
5. Expression of cyclin D1 splice variants is differentially associated with outcome in non-small cell lung cancer patients.
Li R; An SJ; Chen ZH; Zhang GC; Zhu JQ; Nie Q; Xie Z; Guo AL; Mok TS; Wu YL
Hum Pathol; 2008 Dec; 39(12):1792-801. PubMed ID: 18715616
[TBL] [Abstract][Full Text] [Related]
6. Enhanced skin carcinogenesis and lack of thymus hyperplasia in transgenic mice expressing human cyclin D1b (CCND1b).
Rojas P; Benavides F; Blando J; Perez C; Cardenas K; Richie E; Knudsen ES; Johnson DG; Senderowicz AM; Rodriguez-Puebla ML; Conti CJ
Mol Carcinog; 2009 Jun; 48(6):508-16. PubMed ID: 18942117
[TBL] [Abstract][Full Text] [Related]
7. Cyclin D1b represses breast cancer cell growth by antagonizing the action of cyclin D1a on estrogen receptor alpha-mediated transcription.
Zhu J; Sen S; Wei C; Frazier ML
Int J Oncol; 2010 Jan; 36(1):39-48. PubMed ID: 19956831
[TBL] [Abstract][Full Text] [Related]
8. Cyclin D1b splice variant promotes αvβ3-mediated adhesion and invasive migration of breast cancer cells.
Wu FH; Luo LQ; Liu Y; Zhan QX; Luo C; Luo J; Zhang GM; Feng ZH
Cancer Lett; 2014 Dec; 355(1):159-67. PubMed ID: 25193465
[TBL] [Abstract][Full Text] [Related]
9. Knocking down cyclin D1b inhibits breast cancer cell growth and suppresses tumor development in a breast cancer model.
Wei M; Zhu L; Li Y; Chen W; Han B; Wang Z; He J; Yao H; Yang Z; Zhang Q; Liu B; Gu Q; Zhu Z; Shen K
Cancer Sci; 2011 Aug; 102(8):1537-44. PubMed ID: 21521417
[TBL] [Abstract][Full Text] [Related]
10. Consequence of the tumor-associated conversion to cyclin D1b.
Augello MA; Berman-Booty LD; Carr R; Yoshida A; Dean JL; Schiewer MJ; Feng FY; Tomlins SA; Gao E; Koch WJ; Benovic JL; Diehl JA; Knudsen KE
EMBO Mol Med; 2015 May; 7(5):628-47. PubMed ID: 25787974
[TBL] [Abstract][Full Text] [Related]
11. Alternative splicing of the cyclin D1 proto-oncogene is regulated by the RNA-binding protein Sam68.
Paronetto MP; Cappellari M; Busà R; Pedrotti S; Vitali R; Comstock C; Hyslop T; Knudsen KE; Sette C
Cancer Res; 2010 Jan; 70(1):229-39. PubMed ID: 20028857
[TBL] [Abstract][Full Text] [Related]
12. An alternatively spliced cyclin D1 isoform, cyclin D1b, is a nuclear oncogene.
Lu F; Gladden AB; Diehl JA
Cancer Res; 2003 Nov; 63(21):7056-61. PubMed ID: 14612495
[TBL] [Abstract][Full Text] [Related]
13. Identification of ASF/SF2 as a critical, allele-specific effector of the cyclin D1b oncogene.
Olshavsky NA; Comstock CE; Schiewer MJ; Augello MA; Hyslop T; Sette C; Zhang J; Parysek LM; Knudsen KE
Cancer Res; 2010 May; 70(10):3975-84. PubMed ID: 20460515
[TBL] [Abstract][Full Text] [Related]
14. Identification of cyclin D1- and estrogen-regulated genes contributing to breast carcinogenesis and progression.
Yang C; Trent S; Ionescu-Tiba V; Lan L; Shioda T; Sgroi D; Schmidt EV
Cancer Res; 2006 Dec; 66(24):11649-58. PubMed ID: 17178859
[TBL] [Abstract][Full Text] [Related]
15. Cyclin D1b in human breast carcinoma and coexpression with cyclin D1a is associated with poor outcome.
Abramson VG; Troxel AB; Feldman M; Mies C; Wang Y; Sherman L; McNally S; Diehl A; Demichele A
Anticancer Res; 2010 Apr; 30(4):1279-85. PubMed ID: 20530440
[TBL] [Abstract][Full Text] [Related]
16. Combined cyclin D1 overexpression and zinc deficiency disrupts cell cycle and accelerates mouse forestomach carcinogenesis.
Fong LY; Mancini R; Nakagawa H; Rustgi AK; Huebner K
Cancer Res; 2003 Jul; 63(14):4244-52. PubMed ID: 12874033
[TBL] [Abstract][Full Text] [Related]
17. Relevance of cyclin D1b expression and CCND1 polymorphism in the pathogenesis of multiple myeloma and mantle cell lymphoma.
Krieger S; Gauduchon J; Roussel M; Troussard X; Sola B
BMC Cancer; 2006 Oct; 6():238. PubMed ID: 17022831
[TBL] [Abstract][Full Text] [Related]
18. Cyclin K and cyclin D1b are oncogenic in myeloma cells.
Marsaud V; Tchakarska G; Andrieux G; Liu JM; Dembele D; Jost B; Wdzieczak-Bakala J; Renoir JM; Sola B
Mol Cancer; 2010 May; 9():103. PubMed ID: 20459741
[TBL] [Abstract][Full Text] [Related]
19. Convergence of oncogenic and hormone receptor pathways promotes metastatic phenotypes.
Augello MA; Burd CJ; Birbe R; McNair C; Ertel A; Magee MS; Frigo DE; Wilder-Romans K; Shilkrut M; Han S; Jernigan DL; Dean JL; Fatatis A; McDonnell DP; Visakorpi T; Feng FY; Knudsen KE
J Clin Invest; 2013 Jan; 123(1):493-508. PubMed ID: 23257359
[TBL] [Abstract][Full Text] [Related]
20. Identification of the cyclin D1b mRNA variant in mouse.
Wu J; Wu SH; Bollig A; Thakur A; Liao DJ
Mol Biol Rep; 2009 May; 36(5):953-7. PubMed ID: 18446443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
